scispace - formally typeset
A

Aimee Di Marco

Researcher at Imperial College London

Publications -  22
Citations -  246

Aimee Di Marco is an academic researcher from Imperial College London. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 16 publications receiving 186 citations. Previous affiliations of Aimee Di Marco include University of Sydney & King's College London.

Papers
More filters
Journal ArticleDOI

Comparative effectiveness of 3-dimensional vs 2-dimensional and high-definition vs standard-definition neuroendoscopy: a preclinical randomized crossover study.

TL;DR: Three-dimensional neuro endoscopy and HD neuroendoscopy have differing but complementary effects on surgical performance, suggesting that neither alone can completely compensate for the lack of the other.
Journal ArticleDOI

Multispectral image alignment using a three channel endoscope in vivo during minimally invasive surgery.

TL;DR: The ability of this three-channel rigid endoscope system for measuring blood perfusion changes in the tissue during surgery and its potential use as a platform for other sequential imaging modalities are demonstrated.
Journal ArticleDOI

Intraoperative ultrasound overlay in robot-assisted partial nephrectomy: first clinical experience.

TL;DR: This poster presents a prototype probe clip 3D printed in sterilisable Cobalt-Chrome alloy Intraoperative Ultrasound Overlay in Robot-assisted Partial Nephrectomy: First Clinical Experience.
Book ChapterDOI

Intraoperative ultrasound guidance for transanal endoscopic microsurgery

TL;DR: Novel ultrasound calibration and effective visualisation methods designed to meet the requirements for accurate identification and complete removal of lesions and subsurface targets are described, relying solely on optical measurements and pattern tracking.
Journal ArticleDOI

Near-infrared autofluorescence in thyroid and parathyroid surgery.

TL;DR: Despite the promising results of NIR-AF, the absence of data demonstrating an improvement in outcomes and the cost of its use currently limit its use in routine clinical practice, especially in a publicly funded healthcare system with budgetary constraints.